Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Harper

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of the American Society of Nephrology : JASN|March 16, 2022
Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell FenestrationsNatalie C Finch, Sarah S Fawaz, Chris R Neal, et al.
Chemical Science|July 24, 2012
Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoformsJeanette Woolard, William Vousden, Steven J Moss, et al.
Cancer Research|November 3, 2004
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expressionJeanette Woolard, Wen-Ying Wang, Heather S Bevan, et al.
Molecular Oncology|September 17, 2014
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistanceMaryam A Hamdollah Zadeh, Elianna M Amin, Coralie Hoareau-Aveilla, et al.
JCI Insight|February 7, 2023
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyxMichael Crompton, Joanne K Ferguson, Raina D Ramnath, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 30, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular diseaseSohni Ria Bhalla, Mussarat Wahid, Jason O Amartey, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 28, 2006
Remarkable amphibian biomass and abundance in an isolated wetland: implications for wetland conservationJ Whitfield Gibbons, Christopher T Winne, David E Scott, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of the American Society of Nephrology : JASN|March 16, 2022
Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell FenestrationsNatalie C Finch, Sarah S Fawaz, Chris R Neal, et al.
Chemical Science|July 24, 2012
Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoformsJeanette Woolard, William Vousden, Steven J Moss, et al.
Cancer Research|November 3, 2004
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expressionJeanette Woolard, Wen-Ying Wang, Heather S Bevan, et al.
Molecular Oncology|September 17, 2014
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistanceMaryam A Hamdollah Zadeh, Elianna M Amin, Coralie Hoareau-Aveilla, et al.
JCI Insight|February 7, 2023
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyxMichael Crompton, Joanne K Ferguson, Raina D Ramnath, et al.
Cancer Cell|December 17, 2011
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicingElianna M Amin, Sebastian Oltean, Jing Hua, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 30, 2025
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular diseaseSohni Ria Bhalla, Mussarat Wahid, Jason O Amartey, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 28, 2006
Remarkable amphibian biomass and abundance in an isolated wetland: implications for wetland conservationJ Whitfield Gibbons, Christopher T Winne, David E Scott, et al.
Journal of the American Society of Nephrology : JASN|December 28, 2014
Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic NephropathySebastian Oltean, Yan Qiu, Joanne K Ferguson, et al.
Pageof 7